Kate Lapane to Warfarin
This is a "connection" page, showing publications Kate Lapane has written about Warfarin.
Connection Strength
0.827
-
Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016. J Am Heart Assoc. 2019 05 07; 8(9):e012023.
Score: 0.560
-
Alcusky M, Tjia J, McManus DD, Hume AL, Fisher M, Lapane KL. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents. J Gen Intern Med. 2020 08; 35(8):2329-2337.
Score: 0.149
-
Kan V, Lapane K, McManus D, Baek J, Darling C, Alcusky M. Racial disparities and trends in anticoagulant use among ambulatory care patients with atrial fibrillation and atrial flutter in the United States from 2007 to 2019. BMC Health Serv Res. 2025 Oct 03; 25(1):1300.
Score: 0.055
-
Quilliam BJ, Lapane KL. Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke. 2001 Jun; 32(6):1385-93.
Score: 0.040
-
Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke. 2003 Nov; 34(11):2693-7.
Score: 0.012
-
Quilliam BJ, Lapane KL, Eaton CB, Mor V. Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors. Stroke. 2001 Oct; 32(10):2299-304.
Score: 0.010